HSA
- Marketing authorisation holder: 3D IMAGING DRUG
- Status: likely_approved
Fludeoxyglucose F-18 (FLUDEOXYGLUCOSE) regulatory status in Singapore.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA has authorised it.
3D IMAGING DRUG holds the Singaporean marketing authorisation.